QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
Log in
NASDAQ:CCXI

ChemoCentryx News Headlines

$52.23
-3.08 (-5.57 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$51.52
Now: $52.23
$55.75
50-Day Range
$46.35
MA: $52.32
$55.72
52-Week Range
$6.44
Now: $52.23
$65.43
Volume771,789 shs
Average Volume666,012 shs
Market Capitalization$3.60 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.74

Headlines

ChemoCentryx (NASDAQ CCXI) News Headlines Today

Source:
DateHeadline
ChemoCentryx (NASDAQ:CCXI) Raised to Buy at BidaskClubChemoCentryx (NASDAQ:CCXI) Raised to Buy at BidaskClub
marketbeat.com - September 19 at 5:08 AM
ChemoCentryx (NASDAQ:CCXI) Cut to Hold at BidaskClubChemoCentryx (NASDAQ:CCXI) Cut to Hold at BidaskClub
marketbeat.com - August 29 at 9:32 AM
ChemoCentryx (NASDAQ:CCXI) Stock Rating Upgraded by TheStreetChemoCentryx (NASDAQ:CCXI) Stock Rating Upgraded by TheStreet
marketbeat.com - August 22 at 7:21 AM
ChemoCentryx (NASDAQ:CCXI) Sets New 52-Week High After Analyst UpgradeChemoCentryx (NASDAQ:CCXI) Sets New 52-Week High After Analyst Upgrade
marketbeat.com - May 19 at 5:11 PM
ChemoCentryx (NASDAQ:CCXI)  Shares Down 5.6% ChemoCentryx (NASDAQ:CCXI) Shares Down 5.6%
americanbankingnews.com - September 21 at 8:14 PM
FDA accepts ChemoCentryxs avacopan application for blood vessel inflammationFDA accepts ChemoCentryx's avacopan application for blood vessel inflammation
seekingalpha.com - September 19 at 10:21 AM
ChemoCentryxs NDA for Autoimmune Disease Drug Accepted by FDA - NasdaqChemoCentryx's NDA for Autoimmune Disease Drug Accepted by FDA - Nasdaq
nasdaq.com - September 18 at 7:19 PM
ChemoCentryx (NASDAQ:CCXI) Trading 5.2% Higher  on Analyst UpgradeChemoCentryx (NASDAQ:CCXI) Trading 5.2% Higher on Analyst Upgrade
americanbankingnews.com - September 18 at 6:14 PM
ChemoCentryx's NDA for Autoimmune Disease Drug Accepted by FDAChemoCentryx's NDA for Autoimmune Disease Drug Accepted by FDA
finance.yahoo.com - September 18 at 2:19 PM
CCXI To Face FDA In April, CRDF Soars On Colorectal Cancer Trial Data, VCNX In Deal With MRK - NasdaqCCXI To Face FDA In April, CRDF Soars On Colorectal Cancer Trial Data, VCNX In Deal With MRK - Nasdaq
nasdaq.com - September 18 at 4:17 AM
ChemoCentryx (NASDAQ:CCXI) PT Raised to $85.00 at HC WainwrightChemoCentryx (NASDAQ:CCXI) PT Raised to $85.00 at HC Wainwright
americanbankingnews.com - September 17 at 2:37 PM
ChemoCentryx Announces FDA Acceptance of the Avacopan New Drug Application (NDA) for the Treatment of ANCA-Associated Vasculitis - GlobeNewswireChemoCentryx Announces FDA Acceptance of the Avacopan New Drug Application (NDA) for the Treatment of ANCA-Associated Vasculitis - GlobeNewswire
globenewswire.com - September 17 at 1:15 PM
ChemoCentryx Announces FDA Acceptance of the Avacopan New Drug Application (NDA) for the Treatment of ANCA-Associated VasculitisChemoCentryx Announces FDA Acceptance of the Avacopan New Drug Application (NDA) for the Treatment of ANCA-Associated Vasculitis
finance.yahoo.com - September 17 at 1:15 PM
Hedge Funds Aren’t Done Buying ChemoCentryx Inc (CCXI) - Yahoo FinanceHedge Funds Aren’t Done Buying ChemoCentryx Inc (CCXI) - Yahoo Finance
finance.yahoo.com - September 15 at 6:06 AM
Hedge Funds Aren’t Done Buying ChemoCentryx Inc (CCXI)Hedge Funds Aren’t Done Buying ChemoCentryx Inc (CCXI)
finance.yahoo.com - September 15 at 6:06 AM
ChemoCentryx (NASDAQ:CCXI) Stock Price Up 5%ChemoCentryx (NASDAQ:CCXI) Stock Price Up 5%
americanbankingnews.com - September 9 at 9:15 PM
ChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Quarterly Sales of $12.86 MillionChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Quarterly Sales of $12.86 Million
americanbankingnews.com - September 9 at 1:48 AM
ChemoCentryx to Present at the H.C. Wainwright 22nd Annual Global Investment Conference - GlobeNewswireChemoCentryx to Present at the H.C. Wainwright 22nd Annual Global Investment Conference - GlobeNewswire
globenewswire.com - September 8 at 1:37 PM
ChemoCentryx to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceChemoCentryx to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 8 at 1:37 PM
Why Tesla Stock Fell Again on Friday - NasdaqWhy Tesla Stock Fell Again on Friday - Nasdaq
nasdaq.com - September 5 at 4:33 AM
ChemoCentryx Becomes Oversold (CCXI) - NasdaqChemoCentryx Becomes Oversold (CCXI) - Nasdaq
nasdaq.com - September 4 at 11:32 PM
CCXI Makes Notable Cross Below Critical Moving AverageCCXI Makes Notable Cross Below Critical Moving Average
nasdaq.com - September 4 at 6:31 PM
Imagine Holding ChemoCentryx (NASDAQ:CCXI) Shares While The Price Zoomed 652% Higher - Yahoo FinanceImagine Holding ChemoCentryx (NASDAQ:CCXI) Shares While The Price Zoomed 652% Higher - Yahoo Finance
finance.yahoo.com - September 4 at 1:31 PM
Imagine Holding ChemoCentryx (NASDAQ:CCXI) Shares While The Price Zoomed 652% HigherImagine Holding ChemoCentryx (NASDAQ:CCXI) Shares While The Price Zoomed 652% Higher
finance.yahoo.com - September 4 at 1:31 PM
ChemoCentryx (NASDAQ:CCXI)  Shares Down 6.2% ChemoCentryx (NASDAQ:CCXI) Shares Down 6.2%
americanbankingnews.com - September 3 at 8:31 PM
ChemoCentryx Target of Unusually High Options Trading (NASDAQ:CCXI)ChemoCentryx Target of Unusually High Options Trading (NASDAQ:CCXI)
americanbankingnews.com - September 1 at 10:59 AM
ChemoCentryx Inc (CCXI) Q2 2020 Earnings Call Transcript - Motley FoolChemoCentryx Inc (CCXI) Q2 2020 Earnings Call Transcript - Motley Fool
fool.com - August 11 at 8:27 PM
ChemoCentryx Inc (CCXI) Q2 2020 Earnings Call TranscriptChemoCentryx Inc (CCXI) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 11 at 8:27 PM
Edited Transcript of CCXI.OQ earnings conference call or presentation 10-Aug-20 9:00pm GMT - Yahoo FinanceEdited Transcript of CCXI.OQ earnings conference call or presentation 10-Aug-20 9:00pm GMT - Yahoo Finance
finance.yahoo.com - August 11 at 3:27 PM
Tencent’s China Literature Crashes to $465 Million LossTencent’s China Literature Crashes to $465 Million Loss
finance.yahoo.com - August 11 at 3:27 PM
ChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights - Yahoo FinanceChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights - Yahoo Finance
finance.yahoo.com - August 11 at 2:33 AM
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q2 2020 Results - Earnings Call Transcript - Seeking AlphaChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 11 at 2:33 AM
Form 8-K Revolution Medicines, For: Aug 10 - StreetInsider.comForm 8-K Revolution Medicines, For: Aug 10 - StreetInsider.com
streetinsider.com - August 10 at 9:33 PM
Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress - GlobeNewswireRevolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress - GlobeNewswire
globenewswire.com - August 10 at 9:33 PM
ChemoCentryx (CCXI) Q2 Earnings and Revenues Surpass Estimates - Yahoo FinanceChemoCentryx (CCXI) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
finance.yahoo.com - August 10 at 9:33 PM
ChemoCentryx (CCXI) Q2 Earnings and Revenues Surpass EstimatesChemoCentryx (CCXI) Q2 Earnings and Revenues Surpass Estimates
finance.yahoo.com - August 10 at 9:33 PM
ChemoCentryx, Inc. 2020 Q2 - Results - Earnings Call PresentationChemoCentryx, Inc. 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 10 at 5:47 PM
ChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights - GlobeNewswireChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights - GlobeNewswire
globenewswire.com - August 10 at 4:32 PM
ChemoCentryx Reports Second Quarter 2020 Financial Results and Recent HighlightsChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights
finance.yahoo.com - August 10 at 4:32 PM
ChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGSChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS
bloomberg.com - August 10 at 12:03 AM
ChemoCentryx to Hold Second Quarter 2020 Financial Results Conference Call on Monday, August 10, 2020 - Yahoo FinanceChemoCentryx to Hold Second Quarter 2020 Financial Results Conference Call on Monday, August 10, 2020 - Yahoo Finance
finance.yahoo.com - August 3 at 12:36 PM
ChemoCentryx to Hold Second Quarter 2020 Financial Results Conference Call on Monday, August 10, 2020ChemoCentryx to Hold Second Quarter 2020 Financial Results Conference Call on Monday, August 10, 2020
finance.yahoo.com - August 3 at 12:36 PM
Earnings Preview: ChemoCentryx (CCXI) Q2 Earnings Expected to Decline - Yahoo FinanceEarnings Preview: ChemoCentryx (CCXI) Q2 Earnings Expected to Decline - Yahoo Finance
finance.yahoo.com - July 27 at 2:19 PM
Earnings Preview: ChemoCentryx (CCXI) Q2 Earnings Expected to DeclineEarnings Preview: ChemoCentryx (CCXI) Q2 Earnings Expected to Decline
finance.yahoo.com - July 27 at 2:19 PM
CCXI Aug 2020 20.000 callCCXI Aug 2020 20.000 call
uk.finance.yahoo.com - July 27 at 9:19 AM
How Much is ChemoCentryxs (NASDAQ:CCXI) CEO Getting Paid? - Yahoo FinanceHow Much is ChemoCentryx's (NASDAQ:CCXI) CEO Getting Paid? - Yahoo Finance
finance.yahoo.com - July 21 at 7:15 AM
How Much is ChemoCentryx's (NASDAQ:CCXI) CEO Getting Paid?How Much is ChemoCentryx's (NASDAQ:CCXI) CEO Getting Paid?
finance.yahoo.com - July 21 at 7:15 AM
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer - Business WireCircle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer - Business Wire
www.businesswire.com - July 20 at 11:08 AM
Insiders Roundup: Mastercard, ChemoCentryx - Yahoo FinanceInsiders Roundup: Mastercard, ChemoCentryx - Yahoo Finance
finance.yahoo.com - July 17 at 11:08 PM
Insiders Roundup: Mastercard, ChemoCentryxInsiders Roundup: Mastercard, ChemoCentryx
finance.yahoo.com - July 17 at 1:07 PM
Form SC 13D/A ChemoCentryx, Inc. Filed by: Vifor (International) Ltd - StreetInsider.comForm SC 13D/A ChemoCentryx, Inc. Filed by: Vifor (International) Ltd - StreetInsider.com
www.streetinsider.com - July 16 at 9:32 AM
CCXI: 4 Small Caps Ready to Surge - StockNews.comCCXI: 4 Small Caps Ready to Surge - StockNews.com
stocknews.com - July 15 at 1:33 PM
Did Hedge Funds Make The Right Call On ChemoCentryx Inc (CCXI) ?Did Hedge Funds Make The Right Call On ChemoCentryx Inc (CCXI) ?
finance.yahoo.com - July 13 at 2:43 PM
ChemoCentryx files U.S. avacopan application for blood vessel inflammationChemoCentryx files U.S. avacopan application for blood vessel inflammation
seekingalpha.com - July 11 at 8:55 AM
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.